Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Rigel Pharmaceuticals, Inc. (RIGL) had Debt to Equity Ratio of 18.15 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$179.28M |
|
$17.48M |
|
$18.65M |
|
$160.63M |
|
$155.09M |
|
$24.19M |
|
$-5.83M |
|
$18.37M |
|
$18.37M |
|
$17.48M |
|
$17.48M |
|
$17.48M |
|
$17.48M |
|
$24.19M |
|
$25.71M |
|
17.58M |
|
17.69M |
|
$0.99 |
|
$0.99 |
|
| Balance Sheet Financials | |
$135.10M |
|
$0.09M |
|
$28.87M |
|
$163.98M |
|
$63.30M |
|
$52.41M |
|
$97.39M |
|
$160.69M |
|
$3.29M |
|
$-23.81M |
|
$3.29M |
|
17.71M |
|
| Cash Flow Statement Financials | |
$31.47M |
|
$4.13M |
|
$-11.64M |
|
$32.79M |
|
$56.75M |
|
$23.96M |
|
$12.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
0.94 |
|
|
Debt to Equity Ratio |
18.15 |
89.60% |
|
13.49% |
|
13.49% |
|
14.34% |
|
10.24% |
|
9.75% |
|
$31.53M |
|
-- |
|
-- |
|
-- |
|
1.09 |
|
3.11 |
|
4.31 |
|
84.73 |
|
531.79% |
|
-73.43% |
|
10.66% |
|
31.39% |
|
$0.19 |
|
$1.78 |
|
$1.78 |
|